Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Katakowski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Molecular Therapeutics|April 8, 2010
siRNA-based topical microbicides targeting sexually transmitted infectionsJoseph A Katakowski, Deborah Palliser
Discovery Medicine|March 2, 2011
Optimizing siRNA delivery to the genital mucosaJoseph A Katakowski, Deborah Palliser
Drug Discovery Today|March 30, 2025
Drug development for neglected ultra-rare diseases of no commercial interest: Challenges and opportunitiesJoseph A Katakowski, Juan C López
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2014
Aptamer-targeted antigen deliveryBrian C Wengerter, Joseph A Katakowski, Jacob M Rosenberg, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Viral vector-mediated <i>SLC9A6</i> gene replacement reduces cerebellar dysfunction in the <i>shaker</i> rat model of Christianson syndromeCollin J Anderson, Karla P Figueroa, Sharan Paul, et al.
Human Molecular Genetics|April 4, 2026
Viral vector-mediated SLC9A6 gene replacement reduces cerebellar motor and molecular abnormalities in the shaker rat model of Christianson syndromeCollin J Anderson, Karla P Figueroa, Sharan Paul, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2015
Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune ResponsesJoseph A Katakowski, Gayatri Mukherjee, Samantha E Wilner, et al.
Genome Medicine|October 11, 2014
Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cellsElena Tosti, Joseph A Katakowski, Sonja Schaetzlein, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Molecular Therapeutics|April 8, 2010
siRNA-based topical microbicides targeting sexually transmitted infectionsJoseph A Katakowski, Deborah Palliser
Discovery Medicine|March 2, 2011
Optimizing siRNA delivery to the genital mucosaJoseph A Katakowski, Deborah Palliser
Drug Discovery Today|March 30, 2025
Drug development for neglected ultra-rare diseases of no commercial interest: Challenges and opportunitiesJoseph A Katakowski, Juan C López
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 1, 2014
Aptamer-targeted antigen deliveryBrian C Wengerter, Joseph A Katakowski, Jacob M Rosenberg, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Viral vector-mediated <i>SLC9A6</i> gene replacement reduces cerebellar dysfunction in the <i>shaker</i> rat model of Christianson syndromeCollin J Anderson, Karla P Figueroa, Sharan Paul, et al.
Human Molecular Genetics|April 4, 2026
Viral vector-mediated SLC9A6 gene replacement reduces cerebellar motor and molecular abnormalities in the shaker rat model of Christianson syndromeCollin J Anderson, Karla P Figueroa, Sharan Paul, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2015
Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune ResponsesJoseph A Katakowski, Gayatri Mukherjee, Samantha E Wilner, et al.
Genome Medicine|October 11, 2014
Evolutionarily conserved genetic interactions with budding and fission yeast MutS identify orthologous relationships in mismatch repair-deficient cancer cellsElena Tosti, Joseph A Katakowski, Sonja Schaetzlein, et al.
Pageof 1